Mark-David Levin (M-D Levin)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 26

Top Topics

Multiple Myeloma

Chronic Lymphocytic Leukemia

Ejection Fraction

Top Venues

Blood cancer journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Rebecca Svanberg Teglgaard, Hanne Vibeke Hansen Marquart, Hans Jakob Hartling, Jakob Thaning Bay, Caspar da Cunha-Bang, Christian Brieghel, Tereza Faitová, Lisbeth Enggaard, Arnon P Kater, Mark-David Levin, Sabina Kersting, Sisse Rye Ostrowski, Carsten Utoft Niemann
Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Rebecca Svanberg Teglgaard, Hanne Vibeke Hansen Marquart, Hans Jakob Hartling, Jakob Thaning Bay, Caspar da Cunha-Bang, Christian Brieghel, Tereza Faitová, Lisbeth Enggaard, Arnon P Kater, Mark-David Levin, Sabina Kersting, Sisse Rye Ostrowski, Carsten Utoft Niemann
Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Paul J Hengeveld, Joan Hendrik Veelken, Cornelis A M van Bergen, Edwin Quinten, Mischa Y L Vervoordeldonk, Wahija Ismailzada, Rob S Barendse, Julie M N Dubois, Marinus H J van Oers, Christian H Geisler, Arnon P Kater, Peter E Westerweel, Anton W Langerak, Mark-David Levin
Prognosis of IGLV3-21 R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis. Leukemia (2023)
Lina van der Straten, Mark-David Levin, Manette A W Dinnessen, Otto Visser, Eduardus F M Posthuma, Jeanette K Doorduijn, Anton W Langerak, Arnon P Kater, Avinash G Dinmohamed
Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019. Blood cancer journal 13 (1) (2023)
Lina van der Straten, Mark-David Levin, Manette A W Dinnessen, Otto Visser, Eduardus F M Posthuma, Jeanette K Doorduijn, Anton W Langerak, Arnon P Kater, Avinash G Dinmohamed
Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019. Blood cancer journal 13 (1) (2023)
Lina van der Straten, Mark-David Levin, Manette A W Dinnessen, Otto Visser, Eduardus F M Posthuma, Jeanette K Doorduijn, Anton W Langerak, Arnon P Kater, Avinash G Dinmohamed
Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019. Blood cancer journal 13 (1) (2023)
Lina van der Straten, Mark-David Levin, Manette A W Dinnessen, Otto Visser, Eduardus F M Posthuma, Jeanette K Doorduijn, Anton W Langerak, Arnon P Kater, Avinash G Dinmohamed
Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019. Blood cancer journal 13 (1) (2023)
Paul J Hengeveld, J Schilperoord-Vermeulen, M Y van der Klift, J M N Dubois, P M Kolijn, F G Kavelaars, M Rijken, J A Dobber, K Nasserinejad, S Kersting, Peter E Westerweel, Arnon P Kater, Anton W Langerak, Mark-David Levin
Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia. Blood cancer journal 13 (1) (2023)
Tahla Munir, Carol Moreno, Carolyn Owen, George Follows, Ohad Benjamini, Ann Janssens, Mark-David Levin, Anders Osterborg, Tadeusz Robak, Martin Simkovic, Don Stevens, Sergey Voloshin, Vladimir Vorobyev, Munci Yagci, Loic Ysebaert, Keqin Qi, Qianya Qi, Lori Parisi, Srimathi Srinivasan, Natasha Schuier, Kurt Baeten, Angela Howes, Donne Bennett Caces, Carsten Utoft Niemann, Arnon P Kater
Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Lina van der Straten, Carolien C H M Maas, Mark-David Levin, Otto Visser, Eduardus F M Posthuma, Jeanette K Doorduijn, Anton W Langerak, Arnon P Kater, Avinash G Dinmohamed
Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2018. Blood cancer journal 12 (4) (2022)
Mirian Brink, Monique C Minnema, Otto Visser, Mark-David Levin, Eduardus F M Ward Posthuma, Annemiek Broijl, Pieter Sonneveld, Marjolein van der Klift, Wilfried W H Roeloffzen, Matthijs Westerman, Cleo R van Rooijen, Paulus A F Geerts, Sonja Zweegman, Niels W C J van de Donk, Avinash G Dinmohamed
Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands. Blood cancer journal 12 (3) (2022)
Meletios- Athanasios Dimopoulos, Schjesvold Fredrik, Vadim Doronin, Olga Vinogradova, Hang Quach, Xavier Leleu, Yolanda Gonzalez Montes, Karthik Ramasamy, Alessandra Pompa, Mark-David Levin, Cindy Lee, Ulf Henrik Mellqvist, Roland Fenk, Hélène Demarquette, Hamdi Sati, Alexander Vorog, Richard Labotka, Jichang Du, Mohamed Darif, Shaji K Kumar
Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial. Blood cancer journal 12 (1) (2022)
Paul J Hengeveld, Y Emre Ertem, Julie M N Dubois, Clemens H M Mellink, Anne-Marie van der Kevie-Kersemaekers, Ludo M Evers, Kim Heezen, P Martijn Kolijn, Olaf R F Mook, M Mahdi Motazacker, Kazem Nasserinejad, S Kersting, Peter E Westerweel, Carsten Utoft Niemann, Arnon P Kater, Anton W Langerak, Mark-David Levin
Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21 R110 . Leukemia 36 (7) (2022)
Chantal Visser, Maurice Swinkels, Erik D van Werkhoven, F Nanne Croles, Heike S Noordzij-Nooteboom, Matthijs Eefting, Suzanne M Last-Koopmans, Cecile Idink, Peter E Westerweel, Bart Santbergen, Pieter A Jobse, Fazil Baboe, null null, Peter A W Te Boekhorst, Frank W G Leebeek, Mark-David Levin, Marieke J H A Kruip, Arend Jan Gerard Jansen
COVID-19 vaccination in patients with immune thrombocytopenia. Blood advances 6 (6) (2022)
Pieter Sonneveld, Asher Chanan-Khan, Katja Weisel, Ajay K Nooka, Tamas Masszi, Meral Beksac, Ivan Spicka, Vania Tietsche de Moraes Hungria, Markus Munder, Maria-Victoria Mateos-Manteca, Tomer M Mark, Mark-David Levin, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Andrew Spencer
Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, Georgios Karakatsoulis, David John Allsup, Alejandro Alonso Cabrero, Martin Andres, Darko Antic, Mónica Baile, Panagiotis Baliakas, Dominique Bron, Antonella Capasso, Sofia Chatzileontiadou, Raul Cordoba, Juan-Gonzalo Correa, Carolina Cuéllar-García, Lorenzo De Paoli, Maria Rosaria De Paolis, Giovanni Del Poeta, Christos Demosthenous, Maria Dimou, David Donaldson, Michael Doubek, Maria Efstathopoulou, Barbara Eichhorst, Shaimaa El-Ashwah, Alicia Enrico, Blanca Espinet, Lucia Farina, Angela Ferrari, Myriam Foglietta, Henrik Frederiksen, Moritz Fürstenau, Jose Antonio Garcia-Marco, Rocío García-Serra, Massimo Gentile, Eva Gimeno, Andreas Glenthøj, Maria Gomes da Silva, Odit Gutwein, Yervand K Hakobyan, Yair Herishanu, Jose-Ángel Hernández-Rivas, Tobias Herold, Idanna Innocenti, Gilad Itchaki, Ozren Jaksic, Ann Janssens, Оlga B Kalashnikova, Elżbieta Kalicińska, Linda Katharina Karlsson, Arnon P Kater, Sabina Kersting, Jorge Labrador-Gomez, Deepesh P Lad, Luca Laurenti, Mark-David Levin, Enrico Lista, Alberto López-García, Lara Malerba, Roberto Marasca, Monia Marchetti, Juan Marquet, Mattias Mattsson, Francesca R Mauro, Ivana Milosevic, Fatima Mirás, Marta Morawska, Marina Motta, Talha Munir, Roberta Murru, Carsten Utoft Niemann, Raquel Nunes Rodrigues, Jacopo Olivieri, Lorella Orsucci, Maria Papaioannou, Miguel Arturo Pavlovsky, Inga Piskunova, Viola Maria Popov, Francesca Maria Quaglia, Giulia Quaresmini, Kristian Qvist, Gianluigi Reda, Gian Matteo Rigolin, Rosa Ruchlemer, Gevorg Saghumyan, Amit Shrestha, Martin Šimkovič, Martin Špaček, Paolo Sportoletti, Oana Stanca, Niki Stavroyianni, Tamar Tadmor, Doreen Te Raa, Sanne H Tonino, Livio Trentin, Ellen Van Der Spek, Michel van Gelder, Roel van Kampen, Marzia Varettoni, Andrea Visentin, Candida Vitale, Ewa Wasik-Szczepanek, Tomasz Wróbel, Lucrecia Yáñez San Segundo, Mohamed Yassin, Marta Coscia, Alessandro Rambaldi, Emili Montserrat, Caterina Ilari, Antonio Cuneo, Kostas Stamatopoulos, Paolo Ghia
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. Leukemia 35 (12) (2021)
Mirian Brink, Kaz Groen, Pieter Sonneveld, Monique C Minnema, Annemiek Broijl, Avinash G Dinmohamed, Ellen van der Spek, Mark-David Levin, Paula F Ypma, Esther de Waal, Eduardus F M Ward Posthuma, Sonja Zweegman, Niels W C J van de Donk
Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study. Blood cancer journal 11 (11) (2021)
Iris de Weerdt, Roeland Lameris, Jurjen M Ruben, Renate de Boer, Jan Kloosterman, Lisa A King, Mark-David Levin, Paul W H I Parren, Tanja D de Gruijl, Arnon P Kater, Hans J van der Vliet
A Bispecific Single-Domain Antibody Boosts Autologous Vγ9Vδ2-T Cell Responses Toward CD1d in Chronic Lymphocytic Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (6) (2021)
Claudia A M Stege, Kazem Nasserinejad, Ellen van der Spek, Yavuz M Bilgin, Alain Kentos, Maaike Sohne, Roel J W van Kampen, Inge Ludwig, Noortje Thielen, Nazik Durdu-Rayman, Nicole C H P de Graauw, Niels W C J van de Donk, Esther G M de Waal, Marie-Christiane Vekemans, Gert Jan Timmers, Marjolein van der Klift, Savita Soechit, Paulus A F Geerts, Matthijs H Silbermann, Margriet Oosterveld, Inger S Nijhof, Pieter Sonneveld, Saskia K Klein, Mark-David Levin, Sonja Zweegman
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (25) (2021)
Claudia A M Stege, Kazem Nasserinejad, Saskia K Klein, Gert-Jan Timmers, Mels Hoogendoorn, Paula F Ypma, Inger S Nijhof, Gerjo A Velders, Leonie Strobbe, Nazik Durdu-Rayman, Matthijs Westerman, Marjan A Davidis-van Schoonhoven, Roel J W van Kampen, Aart Beeker, Ad Koster, Amanda C Dijk, Niels W C J van de Donk, Ellen van der Spek, Rineke B L Leys, Matthijs H Silbermann, Kaz Groen, Nicole C H P van der Burg-de Graauw, Harm A M Sinnige, Klaas G van der Hem, Henriette Levenga, Yavuz M Bilgin, Pieter Sonneveld, Mark-David Levin, Sonja Zweegman
Improving the identification of frail elderly newly diagnosed multiple myeloma patients. Leukemia 35 (9) (2021)
Pieter Sonneveld, Meletios- Athanasios Dimopoulos, Meral Beksac, Bronno van der Holt, Sara Aquino, Heinz Ludwig, Sonja Zweegman, Thilo Zander, Elena Zamagni, Ruth Wester, Roman Hajek, Lucia Pantani, Luca Dozza, Francesca Gay, AnneMaria Cafro, Luca De Rosa, Annamaria Morelli, Henrik Gregersen, Nina Gulbrandsen, Petra Cornelisse, Rosella Troia, Stefania Oliva, Vincent H J van der Velden, Ka Lung Wu, Paula F Ypma, Gerard M J Bos, Mark-David Levin, Luca Pour, Christoph Driessen, Annemiek Broijl, Alexandra Croockewit, Monique C Minnema, Anders Waage, Cecilie Hveding Blimark, Niels W C J van de Donk, Massimo Offidani, Giuseppe Alberto Maria Palumbo, Andrew Spencer, Mario Boccadoro, Michele Cavo
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (32) (2021)
Paul J Hengeveld, Aaram O Khader, Linda H A de Bruin, Inge G P Geelen, Eske A van Baalen, Eva Jansen, Nathalie I Bouwer, Ömer Balak, Jurgen A Riedl, Anton W Langerak, Peter E Westerweel, Mark-David Levin
Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study. British journal of haematology 190 (4) (2020)
Paul J Hengeveld, Eva de Jongh, Peter E Westerweel, Mark-David Levin
Disseminated cryptococcal disease during treatment with idelalisib and corticosteroids for follicular lymphoma. BMJ case reports 13 (7) (2020)
Iris de Weerdt, Roeland Lameris, George L Scheffer, Jana Vree, Renate de Boer, Anita G Stam, Rieneke van de Ven, Mark-David Levin, Steven T Pals, Rob C Roovers, Paul W H I Parren, Tanja D de Gruijl, Arnon P Kater, Hans J van der Vliet
A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell-Mediated Antitumor Responses in Human B-cell Malignancies. Cancer immunology research 9 (1) (2020)
Paul Geraeds Kemps, Konnie M Hebeda, Steven T Pals, Robert M Verdijk, King H Lam, Annette H Bruggink, Heleen S de Lil, Roelof A Ruiterkamp, Koen de Heer, Jan Am van Laar, Peter Jm Valk, Pim Mutsaers, Mark-David Levin, Pancras C W Hogendoorn, Astrid G S van Halteren
Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation. The journal of pathology. Clinical research 7 (1) (2020)
Mark-David Levin, Arnon P Kater, Mattias Mattsson, Sabina Kersting, Juha Ranti, Hoa Thi Tuyet Tran, Kazem Nasserinejad, Carsten Utoft Niemann
Protocol description of the HOVON 141/VISION trial: a prospective, multicentre, randomised phase II trial of ibrutinib plus venetoclax in patients with creatinine clearance ≥30 mL/min who have relapsed or refractory chronic lymphocytic leukaemia (RR-CLL) with or without TP53 aberrations. BMJ open 10 (10) (2020)